	US 12,214,103 B2
	Products for treating bleeding wounds
Thomas Staffel, Grünstadt (DE); Henrike Thauern, Weinheim (DE); Juergen Straub, Mannheim (DE); Edmund Dolfen, Willich (DE); Carmen Michels, Willich (DE); Karel Krpan, Willich (DE); and Frank-Martin Neumann, Willich (DE)
Assigned to BK GIULINI GMBH, Ladenburg (DE); and FKuR PROPERTY GMBH, Willich (DE)
Appl. No. 17/416,263
Filed by BK GIULINI GMBH, Ladenburg (DE); and FKuR PROPERTY GMBH, Willich (DE)
PCT Filed Dec. 19, 2019, PCT No. PCT/EP2019/086325 § 371(c)(1), (2) Date Jun. 18, 2021, PCT Pub. No. WO2020/127745, PCT Pub. Date Jun. 25, 2020.
Claims priority of application No. 18214785 (EP), filed on Dec. 20, 2018; and application No. 19193416 (EP), filed on Aug. 23, 2019.
Prior Publication US 2022/0105233 A1, Apr. 7, 2022
Int. Cl. A61L 24/00 (2006.01)

CPC A61L 24/0084 (2013.01) [A61L 24/0031 (2013.01); A61L 2400/04 (2013.01)]

20 Claims

1. An agent for use in treating bleeding wounds in mammals, in the form of a flexible sheet material formed from an organic polymer material comprising at least one particulate crystalline inorganic polyphosphate, wherein the organic polymer material forms a sheet-like continuous matrix in which the particles of the particulate crystalline inorganic polyphosphate are present in the organic polymer material in finely divided form, such that the polymer material at least partly surrounds the particles of the particulate crystalline inorganic polyphosphate distributed therein, the polyphosphate at 20° C. having a solubility in deionized water of less than 5 g/L and the anion of the polyphosphate having a number average of at least four phosphorus atoms per polyphosphate anion.